HU’s Impact

1. The Hebrew University's Faculties and Schools

  • 2. NEWS

1. The Hebrew University's Faculties and Schools

Founded by visionaries. Propelled forward by innovation.

The Hebrew University of Jerusalem is one of the world’s most distinguished academic and research institutions. The university is located in Israel, but its work transforms our world. Its students, faculty, and alumni have won eight Nobel Prizes, developed cures for diseases, and spawned innovation that has led to more than 8,900 patents. We think our founding founders, Albert Einstein, Sigmund Freud, Chaim Weizmann, and Martin Buber would be quite proud.
The Hebrew University's List of Faculties and Schools
Robert H. Smith Faculty of Agriculture, Food and Environment
The Smith Faculty has developed groundbreaking innovations such as irrigation technologies, soil solarization, and long shelf-life vegetables. Students take courses in agricultural biotechnology, soil and water sciences, hotel, food and tourism management, and more.
Faculty of Humanities
The Faculty of Humanities focuses on the scope of human civilization in the past and present, as expressed in language, literature, the visual and performing arts, culture, folklore, philosophy, religion, and history.
Faculty of Medicine
Encompasses the School of Pharmacy, School of Occupational Therapy, School of Public Health, School of Nursing, and two research institutes.
Faculty of Mathematics and Sciences
This Faculty is an Israeli leader in the research and teaching of basic and applied science. It encompasses leading academics in the fields of Mathematics, Physics, Chemistry, Life Sciences, and Earth Sciences. The Faculty also incorporates cutting-edge research institutes including: Nanoscience and Nanotechnology, Marine Biogeochemistry, and more.
Faculty of Dental Medicine
Founded in 1953 by the Alpha Omega International Dental Fraternity. The Faculty is Israel's first dental school and is the leading center for dental education, clinical care, research, product/technology development and community outreach.
Faculty of Social Sciences
The Faculty houses nine departments: Geography, International Relations, Economics, Political Science, Sociology and Anthropology, Statistics, Psychology, Communication and Journalism, the Federmann School of Public Policy and Government, an interfaculty program on Internet and Society, and Glocal, an international development master's program.
Faculty of Law
The Faculty is Israel's first law school and is the cornerstone of Israel's legal research and education. It is home to the Minerva Center for Human Rights, the Center for the Study of Multiculturalism and Diversity, the Institute of Criminology, and the Israel Matz Institute for Jewish Law.
Rothberg International School
Attracts more than 2,000 students annually from over 80 countries to its diverse undergraduate and graduate degree exchange programs.
Edmond and Lily Safra Center for Brain Sciences
ELSC is Israel's foremost institute for interdisciplinary brain research and at the forefront of the revolution of neuroscience research. Researchers work to better understand our minds, from alleviating Alzheimer's and Parkinson's symptoms, sensory substitution devices, and more.
Advanced School of Environmental Studies
Consists of the study of environmental policy and resource management. Students learn to be adaptive to the capacity of the populations, and learn tools to rationally evaluate technological solutions for environmental issues.
Federmann School of Public Policy and Government
Seeks to develop the new generation of professional civil servants who will provide the state of Israel–and the Israeli society–with stability and growth.
Koret School of Veterinary Medicine
Israel's first and only veterinary school and the only facility of its kind in the Middle East. The School builds bridges to peace through animal care, shares medical knowledge, and offers joint research projects with countries around the world.
Seymour Fox School of Education
A leader in academic instruction, training, and research. Faculty members advance new ways of thinking about education by using an interdisciplinary approach while accounting for today's social and cultural challenges.
School of Pharmacy
A globally recognized leader in training pharmacists and conducting basic research in drug science. The School trains students for professional practice in the pharmaceutical industry, providing them with a scientific and professional basis. It also offers higher education in pharmacology, medicinal chemistry, and pharmaceutical sciences, as well as a doctoral degree in Clinical Pharmacy.
Hadassah Braun School of Public Health and Community Medicine
On a mission to improve the physical, mental, and social welfare of the global community with a commitment to excellence in multidisciplinary and interdisciplinary public health research, training, and practice.
Paul Baerwald School of Social Work and Social Welfare
Endeavors to further social justice and the personal and social well-being of individuals through path-breaking research and the development of social services and policies for individuals, families, groups, organizations, and communities in Israel and across the globe.
Rachel and Selim Benin School of Computer Science and Engineering
Maintains world-renowned excellence in research and is at the forefront of the technological revolution, with strength in Applied Physics and Biomedical Engineering. The School has a substantial impact on the high-tech industry in Israel.
Jack, Joseph and Morton Mandel School Advanced Studies in the Humanities
Israel's first graduate school in the humanities, the School fosters a dynamic and vibrant academic comunity, prioritzing intellectual interaction, and placing Jewish Studies within the broader fabric of Western and Eastern cultures.
School of Business Administration
Israel's premier academic business school, playing a central role in shaping the Start-Up Nation's business and management leadership ecosystem.



Hebrew U. researchers show which foods prevent, promote...

Foods can determine whether someone will suffer from dementia in later years, according to researchers at the Hebrew University of Jerusalem’s Faculty of Agriculture, Food and Environment in Rehovot.A large-scale international study that included the university recently examined how food affects brain health for people aged 50 and older. The researchers were able to show that diet affects the risk of dementia.This conclusion, although logical, is not self-evident, said Prof. Aron Troen, an expert in nutritional neuroscience and the prevention of cerebrovascular disease and dementia, and the principal investigator of Hebrew University’s Nutrition and Brain Health Laboratory in Rehovot.Among the foods proven to prevent dementia are: blueberries (not just the juice), healthful fats (as in olive oil), nuts (in small amounts to avoid excess calories) and fish. Other beneficial foods include: beans and legumes, fruits, low-calorie dairy products like yogurt, chicken and whole-grain cereals.Among the foods that have been shown to promote dementia are: fried foods, sugary foods, processed foods, red meat, fat, cheese and salt.The report was published in the journal of the American Association of Retired Persons, the most widely circulated journal in the US.The study was conducted in collaboration with dozens of countries, including the US, China, Switzerland and Australia. It examined the scientific basis of preserving brain health and preventing dementia in old age.The team produced a consensus report with convincing evidence that diet affects the risk of dementia.
Read the source article at Jpost

Prof. Sergiu Hart to receive Israel Prize in economic...

Prof. Sergiu Hart of The Hebrew University of Jerusalem will be awarded the Israel Prize for economic research and statistics, the Education Ministry announced on Thursday.Education Minister Naftali Bennett approved the recommendation of the prize committee headed by Prof. Yoav Benjamini.In its decision, the prize committee called Prof. Hart – a former president of the World Association of Game Theory and member of the Academy of Sciences of Israel, Europe and the United States – one of the world’s leading economists.“Prof. Hart specializes in the field of game theory and its comprehensive implications in various economic fields. Among other things, it has an important contribution to the understanding of the convergence to market equilibrium, the value of a player in the game, how cartels are created in the markets and the development of objective risk indices,” the committee wrote.In recent years, it added, Hart’s research has focused on “designing mechanisms such as tenders, which are important in online trade.”Hart was born in Bucharest, Romania, and immigrated to Israel at the age of 14 along with his family. After serving in the IDF, he received undergraduate and graduate degrees from Tel Aviv University in mathematics with honors before completing his post-Doctoral studies at Stanford University in California.In 1991, Hart founded the Center for the Study of Rationality at The Hebrew University, whose academic committee he now chairs.“Under his leadership the center became a unique leader in the world in the study of game theory with its implications in a wide range of fields such as economics, statistics, psychology, law, biology, philosophy and more,” the prize committee wrote in its decision.The Israel Prize is largely regarded as the state’s highest honor. It is presented annually on Independence Day in a state ceremony in Jerusalem attended by the president, the prime minister, the Knesset speaker and the Supreme Court president.Read the source article at Jpost

Guide In Medical of the NGT3 VC Fund Received FDA Approval

Guide In Medical, a medical device startup, which operates as part of the NGT3 Technological Incubator based in Nazareth Israel, has announced receiving FDA market approval for its innovative IRRIS device. The device facilitates performing intubation, an essential and routine medical procedure in which a tube is inserted into the trachea to help open the patient's airway.Guide In Medical is currently in a second financing round to raise $2 million. The Company is poised for setting up distribution systems in Europe, having received CE Marking approval in 2017, and now in the U.S. upon receiving FDA approval. Guide In Medical has so far raised NIS 5 million from CTS, the pharmaceutical, medical equipment and veterinary company, which has joined the Company as a strategic partner, as well as from NGT3 and private investors.The IRRIS was also approved by the Israel Ministry of Health (MOH) and is currently being tested by the intensive care unit of Hadassah Hospital, Mount Scopus. The target audience of the device is physicians in medical centers, paramedics in mobile intensive care units, the army, the police, and other organizations that manage intensive care units.Intubation is a vital and common medical procedure performed under general anesthesia in operating rooms and sometimes also in field conditions.  This is the third most common medical procedure in the U.S., and more than 100 million intubation procedures are performed each year worldwide. The procedure of inserting a tube into the trachea to ventilate the patient requires a high level of skill, maximum precision and speed for quick insertion, as the patient cannot breathe while the procedure is performed. Damage caused by faulty intubation, due to lack of experience of the doctor or paramedic, environmental conditions and/or secretions in the pharynx that obstruct the lungs, and sometimes a different anatomical structure of the patient, may be critical and cost the patient's life.The solution is a non-invasive device, which is attached as a patch to the patient's neck and transmits light of a specific wavelength into the tissues, lighting the inside of the throat. The special light, which blinks clearly, makes it easier for the medical staff to locate the trachea using a video laryngoscope (a device with a video camera) and can more easily guide the insertion of the ventilation tube during intubation.Ariel Shrem, Co-Founder and CEO, Guide In Medical: "The advantages of the device lie in the simplicity of its operation and the ability to quickly and safely identify the trachea even in complicated situations. This is demonstrated by the results of the clinical trials and the positive feedback we received from physicians who have already tried the device. I believe that in the next few years the product will be used in every ambulance, operating room and battalion aid station. FDA approval is an important step in reaching the global market and in recruiting partners for distribution and of course additional investors as part of our growth plan."Zohar Gendler, CEO of NGT3: "Guide In Medical has succeeded in a short time and with maximum efficiency to complete development, conduct three clinical trials, publish two scientific articles, obtain regulatory approvals for marketing in the US, Europe and Canada, and bring on a strategic partner. The company is now turning to its next task of organizing for marketing and going to market."Guide In Medical, a medical device startup, was founded in 2015 based on a collaboration between the entrepreneurs, Itai Hayut, director and technological consultant, Ariel Shrem, CEO of the Company, and Dr. Elchanan Fried, head of the Intensive Care Unit at Hadassah Medical Center on Mt. Scopus and medical consultant of the Company.Guide In Medical has developed an Infrared Red Intubation System (IRRIS) device that facilitates intubation, a vital and common medical procedure in which a tube is inserted into the trachea to ventilate the patient.The technology was created as part of the Hebrew University's Biomedical Entrepreneurship Program in collaboration with Hadassah Medical Center. The Company received an exclusive license to develop the technology from Yissum Research Development Company, the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd.,  the company for commercialization of technologies of Hadassah Medical Organization in Jerusalem.Read the source article at

Prof. Edwin Seroussi to be awarded Israel Prize for...

Prof. Edwin Seroussi of the Hebrew University of Jerusalem will be awarded the Israel Prize for his research in culture, arts and musicology, the Education Ministry announced on Tuesday.Education Minister Naftali Bennett approved the recommendation of the prize committee headed by Prof. Eitan Steinberg.In its decision, the prize committee hailed Prof. Seroussi’s contribution and achievements in the study of Jewish music in the region of Andalusia (Spain and North Africa) and the Ottoman Empire.“Prof. Seroussi is a pioneer in the research of popular music and Sephardi music (dubbed Mediterranean music),” the prize committee wrote. “The fruits of his research in the field of musical heritage and Sephardi liturgical poems have provided a framework for study and performance; and as such, Prof. Seroussi has contributed to imparting them to many [people].”Seroussi was born in Uruguay and immigrated to Israel in 1971 where he completed his undergraduate and graduate degrees in Musicology at Hebrew University. He received his PhD from the University of California Los Angeles.He currently serves as professor of musicology and director of the Jewish Music Research Center at the university.According to the university, his research focuses on the musical cultures of the Mediterranean and the Middle East, interactions between Jewish and Islamic cultures (specifically in art music genres) and popular music in Israel.Bennett tweeted on Monday that he was “especially happy” for the prize committee’s decision because Seroussi’s expertise is in Jewish music from Andalusia (Spain and North Africa) – “fields that have not yet been sufficiently represented.”“Today we bring the full Jewish story, [from] both the West and the East!” he tweeted.Bennett has expressed his support on numerous occasions for empowering Sephardi cultural studies within the general education curriculum and the Jewish narrative.In 2016, he established a committee and appointed Erez Biton as its head, the first poet of Mizrahi descent to win the Israel Prize in Literature (2015). Biton was tasked with empowering the identity of the Mizrahi Jewish community – including immigrants from Egypt, Iraq, Iran, Tunisia and Libya – within the education system.The Israel Prize is largely regarded as the state’s highest honor. It is presented annually on Independence Day in a state ceremony in Jerusalem in the presence of the president, the prime minister, the Knesset speaker and the Supreme Court president. Read the source article at Jpost

Israel Prize in literature to be awarded to David Grossman

Author David Grossman will be awarded the Israel Prize for Hebrew literature and poetry, the Education Ministry announced on Monday.Education Minister Naftali Bennett approved the recommendation of the prize committee headed by Prof. Avner Holtzman and congratulated Grossman.“Since the early 1980’s, David Grossman has taken his place at the center of Israeli culture and he is one of the most profound, moving, and influential voices in our literature,” the prize committee wrote in its decision.In his novels, books, essays, documentary writing, in his extensive creations for children, he presented a series of masterpieces that excel in rich imagination, deep wisdom, human sensitivity, a poignant moral stand and a unique and resonant language,” the prize committee wrote.The committee added that Grossman is one of the most “famous, admired, and beloved” Israeli writers in the world and that his books have been translated into dozens of languages.Bennett defended giving the prize to an author who has been outspoken in his opposition to construction in Israeli settlements and has even backed the European labeling of products from over the Green Line. He told The Jerusalem Post that he has faced criticism from the Right for the decision but that he had no regrets."There are issues on which I disagree with him, but no dispute will remove from the magic of his books," Bennett said. "He is an Israeli patriot who gave the dearest of all to Israel (his son, Staff Sgt. Uri Grossman, 20,  was killed in the 2006 Second Lebanon War). He is not an author of the Left and I am not the education minister of the Right. Hezbollah didn’t ask who is Right and Left and secular and religious when boys with different views were killed in the same tank."Grossman, born in Jerusalem, has written countless novels and children’s books including To the End of the Land, A Horse Walks into a Bar, The Book of Intimate Grammar and Someone to Run With.On Sunday evening, the Education Ministry also announced the Israel Prize winners for research in physics and in psychology.Prof. Shlomo Havlin, of Bar Ilan University, will receive the prize for his research in the field of physics.“Prof. Havlin is one of the pioneers of a number of fields in statistical physics and its implications for complex systems in different areas,” the prize committee wrote in its decision. “Prof. Havlin deals with the generalization of knowledge in physical fields to the broadest areas, such as social networks, technological networks, economic networks, political systems, physiological systems and DNA function.”The committee added that of all Israeli scientists, Prof. Havlin is the most cited by scientists around the world. “He devotes his time and energies to imparting contemporary science to youth and contributes greatly to the creation of scientific ties between Israel and the world,” it wrote.Prof. Yitzhak Shlesinger, of Hebrew University of Jerusalem, was awarded the Israel Prize for his research in psychology.In its decision, the prize committee wrote that Shlesinger is one of the most important scientists in the field of psycholinguistics, contributing to the study of language processing and language development in children.“He was a pioneer in the documentation and conceptualization of sign language in Israel. His work in the field of Talmudic argumentation, in connections with general issues in linguistic expression, is a unique contribution. His innovations are deeply entwined in Hebrew culture and language,” the prize committee wrote.The Israel Prize is largely regarded as the state’s highest honor. It is presented annually on Independence Day in a state ceremony in Jerusalem in the presence of the president, the prime minister, the Knesset speaker and the Supreme Court president.Read the source article at Jpost

One drug could treat Alzheimer’s, MS, Crohn’s and more

Could one drug effectively treat incurable inflammatory diseases such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis and multiple sclerosis as well as neurodegenerative maladies such as Alzheimer’s disease?Yes, says Prof. David Naor, speaking with ISRAEL21c at the Lautenberg Center for General and Tumor Immunology in Hebrew University-Hadassah Medical School, Jerusalem.All these diseases, he explains, are associated with pathological amyloid proteins that could be neutralized by the 5-mer peptide Naor has spent the last 10 years researching and developing with the support of the university’s Yissum technology-transfer company, the Israeli government and Spherium Biomed of Spain.It will take several million dollars to start clinical trials of Naor’s novel, IP-protected peptide — a synthetic protein snippet that significantly reverses the damaging effects of inflammatory diseases and Alzheimer’s disease in mouse models, and restores the learning capacity of Alzheimer’s mice.“I believe that within two years we would know for certain if our academic product can translate into a therapeutic drug to combat inflammatory and neurodegenerative diseases,” Naor says.“Once you control the inflammation, you can control the disease, so our target is to reduce as much as possible the inflammatory activity.”
Prof. David Naor at Hebrew University-Hadassah Medical School, Jerusalem. Photo by Miriam Alster/FLASH90
Rheumatoid arthritisNaor began by studying 5-mer’s effectiveness in rheumatoid arthritis, which affects about one percent of the world population. Currently, about $30 billion worth of biologic drugs are sold each year that effectively control, but cannot cure, rheumatoid arthritis and other inflammatory diseases. Furthermore, these drugs don’t work in one-third of patients.The results of Naor’s experiments were astounding. When mice with collagen-induced arthritis were treated with 5-mer peptide, the severely inflamed tissues in their joints reverted to nearly normal. No harmful side effects were observed.Multiple sclerosis and IBD“Once the rheumatoid arthritis experiment was repeated successfully several times, we looked at a different chronic inflammatory disease – multiple sclerosis, where the inflammation is not in the joints but in the brain,” says Naor.Multiple sclerosis (MS) is the most widespread disabling neurological condition of young adults around the world, usually striking between the ages of 20 and 50. There is no cure, but the Israeli-developed blockbuster drug Copaxone reduces the frequency of relapses.Here, too, Naor’s results were noteworthy. Five days after MS-like disease was induced in mice, 5-mer peptide injections caused a significant decrease in accumulation of inflammatory cells in the central nervous system and significant reduction in limb paralysis. The effects were weaker when the disease was more progressed, but theoretically the peptide could be introduced during a remission phase of MS.Recently, in collaboration with Prof. Haim Ovadia from Hadassah University Medical Center, Naor’s lab achieved another breakthrough by delivering 5-mer peptide via mouth rather than by injections, with the same therapeutic effect.“That means that we may be able to produce pills for oral delivery rather than to provide the drug by injection,” Naor says.Spherium Biomed tests of 5-mer peptide in mouse models of inflammatory bowel diseases (IBD) showed it can reduce the gut inflammation in IBD better than the currently prescribed biological medication, which is effective only in half of IBD patients.Alzheimer’s disease After a quarter-century of failed efforts to develop a cure for Alzheimer’s disease, investment money is dwindling. Yet the number of cases is climbing rapidly along with related costs. About one in nine Americans over 65 has this fatal degenerative neurological disorder affecting 44 million people worldwide.In collaboration with Prof. Hanna Rosenmann from Hadassah, Naor’s lab studied the effect of mer-5 peptide in mice with induced Alzheimer’s disease.Cognitively normal mice placed inside a watery maze learned quickly how to swim to a safe platform and were able to find it faster with every subsequent attempt. But the Alzheimer’s mice took longer finding the platform every time, due to memory difficulties.After treatment with 5-mer peptide, the Alzheimer’s mice regained their ability to learn the location of the platform as quickly as cognitively normal mice.“We can restore the memory of the animal. This doesn’t mean we’re going to cure Alzheimer’s but it does mean we have to do everything possible to see if our peptide could be successful where so many other potential anti-Alzheimer drugs have failed,” says Naor.The 5-mer peptide appears to prevent the accumulation of amyloid–beta in the brain. Amyloid–beta clumps are believed to attract harmful inflammatory cells from the immune system, thus enhancing Alzheimer’s disease.The mechanism of action of the 5-mer peptide was proven on various harmful amyloid proteins, using sophisticated imaging tools in the lab of Prof. Mary Cowman at New York University.“We can inject 5-mer peptide even after the disease has started, and it will work,” says Naor. “We don’t yet know if there is a point of no return when it would no longer work.”Spherium Biomed now seeks funding for the next step, human clinical trials.“Because the peptide was derived from human material, it makes sense that it is going to work in humans at least as well as in mice,” concludes Naor.
Read the source article at ISRAEL21c

3. Partnerships

Pioneering Partnerships

Strategic partnerships are the foundation for tackling the world's greatest challenges. The Hebrew University, a global research powerhouse, collaborates with other world-class academic and cultural institutions to address global needs in the areas of health and medicine, cyber security, and diplomacy to name a few. At the core of these critical alliances are beliefs deeply rooted in the notion that knowledge moves us toward a brighter future.

4. Coursera

Free online courses

We envision a world where anyone, anywhere, can transform their life by accessing knowledge. Explore the Hebrew University of Jerusalem’s free online courses on Coursera.
Learn More